Tianjin Huanhu Hospital

This study tests whether adding a protein called albumin to standard stroke treatment helps people recover better. About 306 adults who had a major stroke and received a clot-removal procedure will be randomly assigned to get either albumin plus standard care or standard care alo…

This study tests whether giving a protein called albumin directly into the brain's artery, right after a clot-removal procedure, can reduce brain damage in people having a major stroke. Sixty adults with a large-vessel blockage in the front part of the brain will be randomly assi…

This early-phase study tests a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty immune cells in people with severe autoimmune diseases like multiple sclerosis, neuromyelitis optica, and myasthenia gravis. Up to 1…